Event

Teresa Dinter

B.S.
Brigham and Women's Hospital / Harvard Medical School

David Chain

M.S.
Sanofi

Nicholas W. Morrell

MD
Addenbrookes Hosp;Addenbrookes Hospital;University of Cambridge

Paul B. Yu

MD, PhD
Brigham and Women's Hospital / Harvard Medical School

Jean Cavallo

PhD
Sanofi

Geoffrey Bocobo

B.S.
Brigham and Women's Hospital / Harvard Medical School

Stephane Illiano

PhD
Sanofi

Noel Southall

PhD
National Center for Advancing Translational Sciences, National Institutes of Health

Zhiqiang Jia

M.D.
Sanofi

Alexander I. Agoulnik

PhD
Florida International University

Shannon C. Dwyer

PhD
Sanofi

Mark Southwood

PhD
Papworth Hosp;Papworth Hospital

Lai-Ming Yung

Ph.D
Brigham and Women's Hospital / Harvard Medical School

Kenneth J. Wilson

PhD
National Center for Advancing Translational Sciences, National Institutes of Health

Juan J. Marugan

PhD
National Center for Advancing Translational Sciences, National Institutes of Health

Marc Ferrer

PhD
National Center for Advancing Translational Sciences, National Institutes of Health

Peiran Yang

Ph.D
Brigham and Women's Hospital / Harvard Medical School

Christopher van Deusen

PhD
Omdana Therapeutics

ML290, an Allosteric Relaxin-RXFP1 Agonist, Attenuates Experimental Pulmonary Hypertension